---
title: "Star Lake Science shareholders Tie Xiaorong and his concerted actors completed a reduction of 2.88% of their shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/244328127.md"
description: "According to the announcement from Star Lake Science, the company received a \"Reduction Result Notification Letter\" jointly issued by shareholder Tie Xiaorong and its concerted party Yipin Group, stating that from April 21, 2025, to June 11, 2025, Tie Xiaorong reduced its holdings in the company by a total of 47,894,950 shares through centralized bidding and block trading, accounting for 2.88% of the company's total share capital"
datetime: "2025-06-12T23:20:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/244328127.md)
  - [en](https://longbridge.com/en/news/244328127.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/244328127.md)
generator: "portal-rs"
---

# Star Lake Science shareholders Tie Xiaorong and his concerted actors completed a reduction of 2.88% of their shares

According to the announcement from Zhitong Finance APP, Star Lake Science (600866.SH) stated that the shareholder Tie Xiaorong and its concerted party Yipin Group jointly issued a "Notice of Reduction Results." From April 21, 2025, to June 11, 2025, Tie Xiaorong reduced its holdings in the company by a total of 47,894,950 shares through centralized bidding and block trading, accounting for 2.88% of the company's total share capital

### Related Stocks

- [600866.CN](https://longbridge.com/en/quote/600866.CN.md)

## Related News & Research

- [REG - AstraZeneca PLC - AstraZeneca completes agreement for Zegfrovy](https://longbridge.com/en/news/297603898.md)
- [DOB Equity takes stake in Uganda solar water provider Irrisol Engineering](https://longbridge.com/en/news/297616977.md)
- [Britain's Octopus Energy acquires Danish automated power trader BD Energy](https://longbridge.com/en/news/297605465.md)
- [Canada's Zoomd Technologies Q2 revenue falls sharply on operating model changes](https://longbridge.com/en/news/297510644.md)
- [PharmaEssentia’s Besremi receives FDA approval for ET](https://longbridge.com/en/news/297630746.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**